Skip to main content
Equibles
CE logo

CE · Celanese Corp

Track CE — free

Use CE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$51.41 +0.15 (+0.29%) At close · Nov 13
S&P 600 member Russell 1000 member Rebalance outlook locked
Market Cap
$5.64B
Shares
109.75M
Volume · Nov 13 1.25M Avg daily vol (3M) 1.63M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$51.41 Open$51.51 Day$50.47–51.60 52W close$35.53–69.24 Avg vol 30d1.5M Short int6.1M · 5.6% of shares · 4.6d Short vol58% Last earningsNov 3, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 3

Up next

Next earnings call
Feb 17, 2027 Est · unconfirmed · in 13 wks
Q3 2026 earnings call transcript
call held Nov 3, 2026
Play latest call

Latest documents

2026
Nov 3
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Sales reach $7,645 million as nine-month profit hits $688 million

Celanese reported nine-month 2026 net sales of $7,645 million, operating profit of $688 million, and net earnings of $255 million. Total debt stood at $11,545 million as of September 30, 2026.

Revenue $2.56B ▲ 5.7% Net income $74M Diluted EPS $0.67
Read from the MD&A section
7 source passages
The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. Nine Months Ended September 30, 2026 | 2025 | Change | 2026 | 2025 | Change Net sales | 2,556 | 2,419 | 137 | 7,645 | 7,340 | 305 Operating profit (loss) | 198 | (1,275) | 1,473 | 688 | (879) | 1,567 Net earnings (loss) | 78 | (1,353) | 1,431 | 255 | (1,173) | 1,428 Total debt | 11,545 | 12,598 Open the document at this passage
Nov 3
Earnings call
Q3 2026 earnings call

Celanese Corp targets approximately $100 million of cost and interest savings next year, expects engineered materials EBITDA growth of approximately 20% year over year versus 2025 excluding Micromax, and sees continued electronics and medical tailwinds.

Nov 2
Current report 8-K
Celanese raises 2026 free cash flow guidance to $750 to $800 million

Celanese reported third quarter 2026 adjusted EPS of $1.65 and $461 million of free cash flow, raised full-year 2026 free cash flow guidance to $750 to $800 million and expects adjusted EPS of $6.00 to $6.25.

Regulation FD disclosure Read from the first part of this long document
4 source passages
This is the Celanese Corporation third quarter 2026 earnings prepared comments. Today, we reported third quarter 2026 adjusted earnings per share of $1.65 (inclusive of approximately $0.36 per share of non-cash transaction amortization1), representing a 23 percent increase compared to the same period last year. I am also pleased to report that we generated $461 million of free cash flow in the quarter. Reflecting the strength of this performance, we are increasing our full-year 2026 outlook and now expect free cash flow of $750 to $800 million. Based on these dynamics, we anticipate full-year 2026 adjusted earnings per share of approximately $6.00 to $6.25. Open the document at this passage
Nov 2
Current report 8-K
Financial results

Celanese Corporation reported third quarter 2026 net sales of $2.6 billion and free cash flow of $461 million. It raised full-year 2026 adjusted earnings per share outlook to approximately $6.00 to $6.25 and free cash flow outlook to $750 to $800 million.

Read from the first part of this long document
Oct 20
Current report 8-K/A Events of Apr 16
Director or officer change, or executive pay

Celanese Corporation appointed Anne P. Noonan to its Compensation and Management Development Committee and its Nominating and Corporate Governance Committee, effective immediately on October 15, 2026.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$9.85B
Trailing 12 months
Net income (TTM)
$262.00M
Trailing 12 months
Revenue growth YoY
+5.7%
Year over year
Operating margin
7.9%
Trailing 12 months
P / E (TTM)
21.7
Trailing earnings · reciprocal yield 4.6%
FCF yield
14.1%
TTM · current market cap
Return on invested capital
4.7%
Trailing 12 months
Net cash
−$10.18B
Latest balance sheet
Dividend yield
0.2%
Trailing 12 months
Shares change YoY
+0.6%
Year over year · more shares
Price change (1Y)
+28.6%
Trailing year
Short interest
5.6%
Latest settlement · 4.6 days to cover
View all 125 metrics

Quarterly results

Revenue Net income Net loss
▼7.7% $2.36B −$1.93B '24 Q4* ▼8.5% $2.39B −$24.00M '25 Q1 ▼4.5% $2.53B $197.00M '25 Q2 ▼8.6% $2.42B −$1.36B '25 Q3 ▼6.5% $2.20B $19.00M '25 Q4* ▼2.2% $2.34B $44.00M '26 Q1 ▲8.7% $2.75B $125.00M '26 Q2 LATEST ▲5.7% $2.56B $74.00M '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

AI Brief

Q3 FY26 earnings call · Nov 3, 2026
Q3 FY26

TL;DR. Celanese delivered improved third-quarter earnings, year-over-year sales growth and strong cash generation, raised full-year free cash flow outlook, advanced divestitures and deleveraging, and expects cost savings and targeted Engineered Materials projects to support future performance. Risks include sequential sales and margin declines, China automotive weakness, fourth-quarter moderation, cost pressure, an Asian supplier outage and delayed Nylon inventory reductions.

Bullish
  • + Acetyl Chain third-quarter sales increased 14% year over year to $1.2 billion, supported by pricing and spot opportunities. new
  • + Existing cost actions are expected to provide another $30 million–$40 million of savings in 2027, mostly EBITDA, alongside about $20 million of functional-cost normalization and $40 million of net interest savings. new
Bearish
  • − Margins declined through the third quarter and finished at lower levels. new
  • − Automotive volumes declined during 2026, driven largely by lower vehicle builds in China. new
  • − Delayed Nylon inventory reductions and softer demand reduced the expected 2026 benefit to approximately $30 million from $45 million. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Strong Sentiment Bearish Fundamentals Strong Quant / Vol High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −1%
below
Price vs 50-day avg +10%
above
RSI (14) 63
neutral
MACD trend Positive
52-week position 47%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +8%
trailing
6-month return −2%
trailing
YTD return +22%
this year
Relative strength −2%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $47 › 200d $52 — 200d above 50d
Institutional flow Distributing
402 of 465 funds reported for Sep 30 · net -1.1M sh shares · +51 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.58% of shares out · ▲ +5.9% MoM · 4.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
465 holders — mid 3-yr range
Squeeze score 78
high risk · 0–100
Fundamentals
Strong
Revenue growth −7%
Y/Y
Gross margin 20%
contracting
EPS growth +25%
Y/Y
Free cash flow $803.0M
Buyback $6.9B
authorized
Balance sheet $11.3B
net debt
Quant / Vol
risk profile
High
Volatility 50%
annualized · 1-yr
Max drawdown −38%
past year
ATR 4.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 2
Latest guidance · from the 8-K filed Nov 2, 2026
full-year 2026
Adjusted earnings per share Non-GAAP $6.00 – $6.25
full year 2026
Effective tax rate for 2026 adjusted earnings Non-GAAP 8%
by the end of 2027
Divestiture sales proceeds $1B
Previous outlook earlier release · from the Earnings Call filed Aug 5, 2026

Still-open targets the latest release did not restate under the same label.

Free cash flow · 2026 $700M – $800M
Divestitures · by the end of 2027 $500M
Other activities · after 26 $75M
Prior guidance period ended · from the 8-K filed May 5, 2026
Adjusted earnings per share · second quarter 2026 $2.00 – $2.40
Guided vs delivered · last 2 settled
Earnings per share 2022
guided $13.00 – $14.00
$17.34 Beat +28.4%
EPS full year
guided $9.50 – $10.00
$16.86 Beat +72.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 5 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−1% Neutral
Price vs 50-day avg
+10% Bullish
RSI (14)
63 Neutral
MACD trend
Positive Bullish
52-week position
47% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $47 › 200d $52 — 200d above 50d
Institutional flow Distributing
402 of 465 funds reported for Sep 30 · net -1.1M sh shares · +51 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.58% of shares out · ▲ +5.9% MoM · 4.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
465 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $36 Now $51 · 47% Range high $69
vs 200-day avg -1% vs 50-day avg +10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Acetyl Chain adjusted EBIT non-GAAP $321M second quarter 2026 —
Acetyl Chain operating EBITDA non-GAAP $385M second quarter 2026 —
Adjusted earnings (loss) from continuing operations per share non-GAAP $2.45 Q2 '26 —
Adjusted earnings per share non-GAAP $2.45 second quarter 2026 —
GAAP → non-GAAP reconciliation
GAAP Net earnings (loss) attributable to Celanese Corporation 125M
+2M (Earnings) loss from discontinued operations
-10M Interest income
+186M Interest expense
+0M Refinancing expense
+11M Income tax provision (benefit)
+156M Certain Items attributable to Celanese Corporation (Table 8)
= Adjusted EBIT 470M
Engineered Materials adjusted EBIT non-GAAP $234M second quarter 2026 —
Engineered Materials operating EBITDA non-GAAP $335M second quarter 2026 —
Free cash flow non-GAAP $140M second quarter 2026 —
GAAP → non-GAAP reconciliation
GAAP Net cash provided by (used in) operating activities 209M
-62M Capital expenditures on property, plant and equipment
-7M Contributions from/(Distributions) to NCI
= Free cash flow 140M
Free cash flow as % of Net sales non-GAAP 5.1% Q2 '26 —
Net debt non-GAAP $10.64B Q2 '26 —
GAAP → non-GAAP reconciliation
GAAP Adjusted EBIT $470M
+$179M Depreciation and amortization expense(1)
= Operating EBITDA $649M
Operating EBITDA Margin non-GAAP 23.6% Q2 '26 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CE
Celanese Corp
this stock
$5.64B +21.6% -7.1% 21.7 5.6%
SHECF
Shin-Etsu Chemical Co., Ltd.
 $63.83B +9.9% — — 0.1%
DOW
Dow Inc.
 $23.92B +41.3% -7.0% — 3.8%
MEOH
Methanex Corp
 $5.45B +77.5% — — 3.1%
SVYSF
Solvay S A
 $2.86B -14.1% — — 0.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
463
% held
112.6%
Reported
402 of 465
Top holder
Dodge & Cox
Held Float
View
Held by Funds
Fund positions
399
View
Short & Settlement
Short Interest Rising
Shares short
6.1M
Days to cover
4.6d
Change
+339.1K sh
View
Short Volume
Short vol %
58%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
1.1K
Value
$51.1K
As of
Oct 13, 2026
View
Off-Exchange
Off-exchange %
40.0%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Kathy Manning
Amount
$1.0K–$15.0K
Traded
Aug 3, 2022
View
Financials
Financials
Revenue (FY)
$9.5B
Net income (FY)
$-1.2B
EPS diluted
$-10.64
View
Buybacks
Authorized
$6.9B
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 3, 2026
This year
24

Celanese reported nine-month 2026 net sales of $7,645 million, operating profit of $688 million, and net earnings of $255 million. Total debt stood at $11,545 million as of September 30, 2026.

View
Proposed Sales
Value
$1.4M
Shares
27.9K
Filed
May 9, 2025
View
Earnings & Events
Webcasts
Last webcast
Nov 3, 2026
View
Investor Relations
Latest news
Celanese Completes Sale of Nutrin…
Published
Nov 12, 2026
View

Performance

5D 20D 120D MTD YTD
CE +10.6% +8.3% -1.8% +4.3% +21.6%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY +8.0% +9.4% -2.3% +4.5% +11.0%

Capital returns

Latest dividend
$0.03 / share · ex Oct 27, 2026
Cut 95.7%
Paid (TTM)
$0.12 / share · 4 payouts
Dividend yield (TTM, derived)
0.23%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$6.87B
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1306830 CUSIP 150870103 13F (30d) 362 filings 315 filers Visit website Investor relations